Loading...

Table of Content

    31 August 2022, Volume 27 Issue 8
    Frontier, Exploration and Controversy
    Differential expression and prognostic value of serum miRNA in patients with hepatitis B virus-related acute-on-chronic liver failure
    XIE Zhi-wei, LU Ai-qi, YANG Ke-li, CHEN Bin-bin, GUAN Yu-juan, XIAO Guang-ming, LI Jian-ping
    2022, 27(8):  853-857. 
    Asbtract ( 165 )   PDF (911KB) ( 208 )  
    References | Related Articles | Metrics
    Objective To investigate the prognostic value of serum miRNA in hepatitis B virus-related chronic and acute liver failure (HBV-ACLF), and to guide clinical diagnosis and treatment.Methods Patients with hepatitis B virus infection admitted to our hospital from May 2018 to May 2019 were enrolled. All the patients were divided into HBV-ACLF group and chronic hepatitis B (CHB) group, a health control (HC) group was also established. The differential expression of miRNA among the 3 groups were analyzed.Results A total of 75 patients (59 males and 16 females) were included, with an average age of 39.7±9.1 years. There were 30 patients in HBV-ACLF group (17 cases were improved and 13 cases were not cured), 20 cases in CHB group and 25 cases in HC group. There was no significant difference in sex, age, creatinine level and white blood cell count among the 3 groups (P>0.05). Compared with cases in CHB group and HC group, patients in HBV-ACLF group had lower erythrocyte count, hemoglobin level and platelet count (P<0.001), higher levels of alanine aminotransferase, aspartate aminotransferase (P<0.001). The expression levels of miRNA-144-3P, miRNA-205-5p, miRNA-96-5p and miRNA451a were significantly up-regulated in HBV-ACLF group (P<0.05). In HBV-ACLF group, the expression levels of miRNA-205-5p and miRNA-96-5p in patients with condition improved were up-regulated, the difference was statistically significant (P<0.05).Conclusion The miRNA expression profiles in patients with HBV-ACLF is significantly different from that in CHB patients and healthy people. High expression of miRNA 205-5p and miRNA 96-5p in patients with HBV-ACLF may indicate a good prognosis.
    Efficacy and safety of tenofovir alafenamide fumarate in the treatment of CHB patients complicated with fatty liver disease
    LU Jia-hui, ZHANG Cong-nan, HE Peng-yuan, OU Meng-dang, HUANG Ming-xing
    2022, 27(8):  858-862. 
    Asbtract ( 884 )   PDF (735KB) ( 250 )  
    References | Related Articles | Metrics
    Objective To explore the efficacy and safety of tenofovir alafenamide fumarate (TAF) in the treatment of chronic hepatitis B (CHB) patients complicated with fatty liver disease.Methods A total of 86 patients with CHB and fatty liver disease diagnosed and treated in our hospital from June 2019 to September 2020 were enrolled. They were divided into a the treatment-naive group (22 cases) and a treatment-experienced group (64 cases). The clinical markers of 2 groups were compared at baseline and 48 weeks after treatment.Results After 48 weeks of treatment in treatment-naive group, the undetected rate and the ratio of hepatitis B virus (HBV) DNA less than 20 IU/mL (50.0% vs 0.0%, 22.7% vs 0.0%, respectively, P<0.001) were higher than those at baseline. The levels of beta2-microglobulin (β2-MG) (median 1.82 mg/L vs 2.02 mg/L, P<0.001) and fasting blood glucose (median 5.11 mmol/L vs 5.41 mmol/L, P<0.001) at 48 weeks after treatment were lower than those at baseline, and the difference was statistically significant. In the treatment-experienced group, the undetected rate of HBV DNA at 48 weeks after treatment was higher than that at baseline, and the rate of HBV DNA more than 20 IU/mL at 48 weeks after treatment was lower than that at the baseline (64.1% vs 39.1%, 12.5% vs 35.9%, respectively, P=0.003); Total cholesterol (TC) (median 4.71 mmol/L vs 4.00 mmol/L, P<0.001), triglyceride (TG) (median 2.19 mmol/L vs 2.00 mmol/L, P<0.001), high-density lipoproteincholesterol (HDL-C) (median 1.16 mmol/L vs 1.00 mmol/ L, P<0.001) at 48 weeks after treatment were higher than those at baseline, low-density lipoprotein cholesterol (LDL-C) (median 2.61 mmol/L vs 3.00 mmol/L, P<0.001) and fasting blood glucose at 48 weeks after treatment (median 5.60 mmol/L vs 6.00 mmol/L, P<0.001) were lower than those at baseline, the differences were statistically significant.Conclusion CHB patients complicated with fatty liver disease in treatment-naive and treatment-experienced group can achieve higher virological and biochemical responses after treated with TAF, and the renal impairment of TAF is lower. However, TAF may have potential effect on increasing TCH, TG and HDL-C levels, lowering fasting blood sugar.
    Changes of serum TIMP-1 and M-CSF levels in patients with chronic hepatitis B treated with long-term antiviral therapy
    ZHANG Lei, HUANG Yu-hong, LUO Ling, WANG Li-ping, FANG Chun-hua, RAN Bin, LI Ying
    2022, 27(8):  863-867. 
    Asbtract ( 167 )   PDF (723KB) ( 186 )  
    References | Related Articles | Metrics
    Objective To investigate the changes of serum tissue matrix metalloproteinase inhibitor-1 (TIMP-1) and macrophage colony stimulating factor (M-CSF) levels in patients with chronic hepatitis B (CHB) treated with long-term antiviral therapy.Methods Between April 2017 and February 2019, 148 patients with CHB admitted to our hospital were the subjects of study and received continuous antiviral therapy for 2 years. The changes of serum TIMP-1 and M-CSF levels before and after treatment were observed. The occurrence of liver cirrhosis in CHB patients was counted and divided into an occurrence group and a non-occurring group according to whether or not liver cirrhosis occurred. The clinical data of patients in the occurrence group and the non-occurrence group were compared. Logistic multivariate regression analysis of factors affecting the occurrence of liver cirrhosis in patients with CHB. A receiver operating characteristic curve (ROC) was made, and the area under the curve (AUC) was used to evaluate the predictive power of changes in serum TIMP-1 and M-CSF on the occurrence of liver cirrhosis in patients with CHB.Results Compared with 1 day before treatment, serum TIMP-1 and M-CSF of CHB patients were reduced after 6 months after treatment (P<0.05), and ΔTIMP-1 and ΔM-CSF were (56.6± 8.3) μg/L, (62.5±9.2) ng/L. The incidence of liver cirrhosis after 2 years of treatment was 24.32%. The occurrence group alanine aminotransferase (ALT), hepatic portal vein diameter, liver elasticity value (LSM), TIMP-1, TIMP-1 after 6 months of treatment, and M-CSF after 6 months of treatment were all higher than those of the non-occurring group (P<0.05), ΔTIMP-1 and ΔM-CSF were lower than those in the non-occurring group (P<0.05). Logistic regression analysis showed that LSM, ΔTIMP-1 and ΔM-CSF were all risk factors affecting liver cirrhosis in patients with CHB (OR=2.732, 3.040, 3.330, P<0.05). ROC analysis showed that the best cut-off points of serum ΔTIMP-1 and ΔM-CSF for predicting the occurrence of liver cirrhosis in CHB patients were 50.9 μg/L and 61.4 ng/L, respectively, the sensitivity was 80.6%, 72.2%, and the specificity was 75.9%, 80.4%, and the AUC were 0.848 and 0.809, respectively.Conclusion Serum ΔTIMP-1 and ΔM-CSF have higher predictive power in predicting the occurrence of liver cirrhosis in CHB patients, and can be used as important reference indexes of whether CHB patients have liver cirrhosis. .
    Liver Fibrosis & Cirrhosis
    Effect of acute kidney injury on clinical prognosis of patients with hepatitis B virus related decompensated liver cirrhosis
    XIE Qiao-hua, WANG Wei, TANG Long, CHEN Jia-lin, SU Miao-fang, CAI Qi-zhi
    2022, 27(8):  868-870. 
    Asbtract ( 182 )   PDF (673KB) ( 195 )  
    References | Related Articles | Metrics
    Objective To investigate the effect of acute kidney injury (AKI) on the clinical prognosis of patients with hepatitis B virus related decompensated liver cirrhosis (HBV-DLC).Methods A total of 176 patients with HBV-DLC (111 males and 65 females) admitted to our hospital from January 2017 to December 2020 were enrolled, with an age of (48.0±8.4) years. Patients were divided into AKI group and non-AKI group according to whether combined with AKI. According to the type of data, t-test or chi-square test was used for comparison, and Log-Rank test was used for survival rate comparison.Results There were 65 cases in AKI group and 111 cases in non-AKI group. The ages of non-AKI group and AKI group were (47.2±8.2) years and (49.8±9.2) years, the difference was statistically significant (P<0.05). There were 78 cases (64.4%) and 47 cases (85.4%) with esophageal varices in non-AKI group and AKI group, the difference was statistically significant (P<0.05). The percentage of neutrophils, international normalized ratio (INR), total bilirubin (TBil), serum creatinine (Scr), blood urea nitrogen (BUN), serum sodium and serum potassium [(68.5±8.6)%, (1.3±0.2), (39.2±12.8) μmol/l, (68.9±21.8) μmol/L, (9.3±2.1) mmol/L, (138.4±8.0) mmol/L and (4.0±0.8) mmol/L] in the non-AKI group were significantly lower than those in the AKI group, [(78.4±9.6) %, (1.5±0.2), (70.5±19.2) μmol/l, (170.7±66.8) μmol/l, (13.7±2.5) mmol/l, (129.0±7.6) mmol/l and (4.7±1.0)mmol/l]m, (P<0.05). Model for end stage liver disease (MELD) scores of non-AKI group and AKI group were (15.5±3.6) points and (24.7±5.7) points, the difference between the 2 group was statistically significant (P<0.05). There were 39 cases (32.2%) and 31 cases (56.4%) combined with infection in non-AKI group and AKI group, the difference between the 2 group was statistically significant (P<0.05). All patients were followed up effectively for 3 months, and the end point of follow-up was death related to HBV-DLC. The 28-day survival rates of non-AKI group and AKI group were 87.6% (106/121) and 65.4% (36/55), and the difference was statistically significant (P<0.05). The 90-day survival rates of non-AKI group and AKI group were 75.2% (91/121) and 43.6% (24/55), with statistically significant (P<0.05).Conclusion The clinical prognosis of patients with HBV-DLC is poor while complicated with AKI. Many blood biochemical indexes increase obviously with the stage of AKI increasing, which deserves clinical attention.
    Analysis of etiology and clinical characteristics in 986 patients with liver cirrhosis
    TONG Yin-ni, ZHENG Ji-min, HAN Dan, JIANG Ping, WANG Cun-kai, WANG Yu-zhen, BAI Yun
    2022, 27(8):  871-873. 
    Asbtract ( 254 )   PDF (762KB) ( 238 )  
    References | Related Articles | Metrics
    Objective To investigate the etiology and clinical characteristics of patients with liver cirrhosis with first hospitalization in recent 5 years. And to prevent, diagnose and treat liver cirrhosis based on etiology, as well as improve the survival rates.Methods The clinical data of patients with liver cirrhosis admitted to our hospital from January 2016 to December 2020 were retrospectively analyzed. The distribution of causes was recorded. The clinical data of plasma D-dimer levels in different liver functional status of cirrhosis, ascites, and spontaneous bacterial peritonitis (SBP) were collected. And the clinical significances were analyzed.Results Among the 986 patients with liver cirrhosis, 431 complicated with hepatitis B virus (HBV) infection, 146 complicated with alcoholic liver disease and 124 complicated with cryptogenic liver disease. There were significant differences in plasma D-dimer levels among different Child-pugh classification, (Child-pugh score C > B >A, P<0.05). The median of plasma D-dimer in ascites group and non-ascites group were 2.16 mg/L and 0.49 mg/L, respectively (P<0.05); The median of D-dimer in ascites SBP groupand non-ascites group were 4.52 mg/L and 1.98mg/L, respectively (P<0.05).Conclusion The main cause of liver cirrhosis is still HBV infection. The D-dimer level of patients with liver cirrhosis is closely related to the severity of liver function injury. If the level of D-dimer is significantly increased, ascites and SBP should be paid more attention to.
    Clinical significance of portal vein thrombosis in patients with HBV related decompensated liver cirrhosis
    WANG Li-hui, WANG Rong-xi, ZHAO Ze-yuan, GUO Zhen-kai
    2022, 27(8):  874-876. 
    Asbtract ( 164 )   PDF (672KB) ( 214 )  
    References | Related Articles | Metrics
    Objective To investigate the incidence and influencing factors of portal vein thrombosis (PVT) in patients with hepatits B virus related decompensated liver cirrhosis (HBV-DLC).Methods A total of 242 patients with HBV-DLC (164 males and 78 females) admitted to our hospital from January 2012 to June 2017 were enrolled. Among all the patients, there were 28 cases with PVT and 214 cases without PVT, and the average age was (51.6±7.6) years. Univariate analysis and multivariate analysis were performed to determine independent risk factors.Results The ages of PVT group and non-PVT group were 55 (46, 63) and 51 (43, 59) years old, and the difference was statistically significant (Z=6.004, P<0.05). There were 15 males in PVT group (53.6%) and 162 males in non-PVT group (75.7%), and the difference was statistically significant (χ2=-6.172, P<0.05). There were 14 cases (50.0%) and 38 cases (17.8%) with variceal bleeding in PVT group and non-PVT group, with statistically significant (χ2=15.258, P<0.05). There were 6 cases and 22 cases with diabetes mellitus in PVT group (21.4%) non-PVT group (10.3%), the difference was statistically significant (χ2=3.008, P<0.05). Total bilirubin, international normalized ratio (INR), D-dimer, model for end stage liver disease (MELD) score and Child-Pugh score in PVT group were 27.8 (18.0, 53.5) μmol/L, 1.4 (1.3, 1.6), 2.1 (1.0, 4.9), 12 (9, 15) points, 8 (7, 10) points, which were significantly different from those in non-PVT group [95.4(32.5, 280.8) μmol/L, 1.6(1.3, 2.0), 1.2(0.5, 2.9), 17(12, 24) points, 10(8, 11) points], (Z=-15.635, -6.006, 10.581, -9.130 and -6.384, P<0.05). There were 6 cases (21.4%) and 8 cases (3.7%) with splenectomy in PVT group non-PVT group, the difference was statistically significant (χ2=14.216, P<0.05). There were 6 cases (21.4%) and 10 cases (4.7%) with endoscopic sclerotherapy in PVT group and non-PVT group, the difference was statistically significant (P<0.05). There was no significant difference in ascites, white blood cell (WBC), drinking history, platelet (PLT), creatinine and transjugular intrahepatic portosystemic shunt (TIPS) between the 2 groups (P>0.05). Taking all influencing factors with statistical differences as independent variables and the occurrence of PVT in patients with HBV-DLC was regarded as dependent variable (0 = no PVT, 1 = PVT). The results of analysis showed that age, splenectomy and endoscopic sclerotherapy were independent risk factors for PVT in HBV-DLC patients (P<0.05).Conclusion Advanced age, splenectomy and endoscopic sclerotherapy are related to the occurrence of PVT in patients with HBV-DLC, which deserves more clinical attention.
    Clinical value of GPR parameter model combined with Fibroscan for evaluating the stage of liver fibrosis in patientes with chronic hepatitis B
    ZHANG Xin, ZHU Gui-juan, YE Xiao-hang, ZHANG Rong-rong, ZHANG Rui, ZHU Li-yao, YAO Meng-chu
    2022, 27(8):  877-880. 
    Asbtract ( 174 )   PDF (740KB) ( 212 )  
    References | Related Articles | Metrics
    Objective To investigate the clinical value of GPR parameter model combined with FibroScan for evaluating the stage of liver fibrosis in patients with chronic hepatitis B (CHB).Methods A total of 161 patients with CHB who underwent liver biopsy in our hospital were selected. The clinical date liver stiffness measurement (LSM), gamma-glutamyl transpeptidase (GGT), platelet (PLT) and GPR at 1 week before puncture were collected. To analyze the correlation between GPR, LSM and the degree of liver fibrosis; to analyze the accuracy of GPR parameter model combined with FibroScan in the diagnosis of liver fibrosis in CHB patients.Results The liver LSM values of CHB patients with degree of fibrosis from F0 to F4 were 5.06±1.48, 5.65±1.48, 6.29±1.14, 8.65±2.75 and 14.03±4.24KPa, respectively; and the differences were statistically significant (F=64.327, P<0.001). The LSM value was positively correlated with the stage of pathology (r=0.730, P<0.001). The GPR values of CHB patients with degree of fibrosis from F0 to F4 were 0.32±0.22, 0.46±0.40, 0.57±0.50, 0.80±0.72 and 1.20±1.06, respectively; and the differences were statistically significant (F=4.921, P<0.001). The GPR value was also positively correlated with pathological staging (r=0.384, P<0.05). The area under the curve (AUC) values of LSM, GPR, and LSM combined with GPR for the diagnosis of F≥2 were 0.851, 0.711, and 0.862, respectively. The AUC values of LSM, GPR, and LSM combined with GPR for the diagnosis of F≥3 were 0.899, 0.722 and 0.911, respectively. The AUC values of LSM, GPR, and LSM combined with GPR for the diagnosis of F=4 were 0.921, 0.711 and 0.926, respectively.Conclusion The predictive value of LSM combined with GPR in the diagnosis for liver fibrosis is better than that of LSM or GPR alone. GPR parameter model combined with Fibroscan can be used as a more accurate non-invasive diagnosis model for liver fibrosis, which is worthy of clinical application.
    An analysis on isolated strains and drug sensitivity in patients with hepatitis B-related cirrhosis comorbided with pulmonary infection
    YAO chao-guang, LAN Jing, HUANG Li, CHEN Li-fen, QIN Dong-lin, HUANG Jie-jie, HUANG Jia
    2022, 27(8):  881-883. 
    Asbtract ( 152 )   PDF (697KB) ( 208 )  
    References | Related Articles | Metrics
    Objective To observe the isolated bacterial strains and drug sensitivity in patients with hepatitis B-related cirrhosis comorbided with pulmonary infection.Methods The clinical data of 123 cases of patients with hepatitis B-related cirrhosis complicated with pulmonary infection were retrospectively analyzed. Sputum samples were collected from all patients. The distribution of isolated bacterial strains and drug sensitivity were analyzed.Results Of the pathogenic bacteria, there were 60.40% of gram negative bacteria, 38.26% of gram positive bacteria, and 1.34% of fungi. Gram-negative bacteria were the main pathogens. The main isolated strains of gram-negative bacteria and gram-positive bacteria were resistant to a variety of antibiotics, the sensitivity rates of Klebsiella pneumoniae to ertapenem, imipenem and amikacin were more than 70%. The sensitivity rates of Escherichia coli to ceftazidime, aztreonam, ertapenem, imipenem and amikacin were more than 70%. The sensitivity rates of Staphylococcus aureus to vancomycin, ciprofloxacin and Levofloxacin etc. were more than 70%. The sensitivity rates of coagulase negative Staphylococcus to vancomycin were more than 70%. Klebsiella pneumoniae and Escherichia coli strains have certain positive rates of extended-spectrum β-lactamase (ESBL) (>30%) and carbapenemase (<30%).Conclusion The strains isolated from patients with hepatitis B related cirrhosis and pulmonary infection are mainly gram-negative bacteria. Gram-negative and gram-positive isolates are resistant to a variety of antibiotics. Klebsiella pneumoniae and Escherichia coli strains are positive for ESBL.
    Liver Cancer
    CT and MRI findings in four cases of hepatic angiosarcoma
    RONG Xue-fei, LIU Shu-hong, DONG Jing-hui, REN Hong-wei
    2022, 27(8):  884-886. 
    Asbtract ( 404 )   PDF (1003KB) ( 261 )  
    References | Related Articles | Metrics
    Objective To investigate the specific manifestation of hepatic angiosarcoma under computer tomography (CT) and magnetic resonance imaging (MRI).Methods The CT and MRI features of four cases of hepatic angiosarcoma (HA) confirmed by pathology in the Fifth Medical Center of PLA General Hospital in Beijing were retrospectively analyzed.Results All 4 HA patients had multiple lesions. One patient had lesions with scar and hepatic artery crossing. All 4 patients had bleeding within the lesions, which was shown by CT as uneven low-density shadow in the lesions, and by MRI as low intensity signal on T1WI, high intensity signal on T2WI, mixed or slightly high intensity signal on DWI, and high signal on apparent diffusion coefficient (ADC). Dynamic enhanced scanning showed patchy enhancement at the edge or within the lesion at arterial stage in all patients. With time extension, the enhancement range of the lesion increased, namely centripetal or eccentric enhancement.Conclusion The CT and MRI findings of HA have certain imaging characteristics. Features of multiple lesions, internal bleeding, high signal on ADC, centripetal and eccentric enhancement on dynamic enhanced scan indicate hepatic angiosarcoma.
    The expressions of CK19, Ki67 and CK7 in hepatocellular carcinoma tissues
    ZHOU Jin-hong, CHONG Yang
    2022, 27(8):  887-890. 
    Asbtract ( 1547 )   PDF (677KB) ( 301 )  
    References | Related Articles | Metrics
    Objective To observe the expression of cytokeratin 19 (CK19), proliferating cell nuclear antigen (Ki67) and cytokeratin 7 (CK7) in primary hepatocellular carcinoma (HCC) tissues.Methods 65 patients with HCC hospitalized from March 2016 to March 2018 were selected as the research objects. The specimens of cancer tissue and adjacent normal tissue were taken during operation. The expressions of CK19, Ki67 and CK7 were measured by immunohistochemical staining. The positive rates of CK19, Ki67 and CK7 between cancer tissues and adjacent tissues were compared. The positive detection rates of CK19, Ki67 and CK7 in cancer tissues of HCC patients with different clinicopathological features were counted and compared. The 3-year survival of HCC patients with different expression levels of CK19, Ki67 and CK7 were analyzed.Results The positive rates of CK19, Ki67 and CK7 in cancer tissues were 40.00%, 73.85% and 70.77% respectively, which were significantly higher than those of 1.54%, 23.08% and 1.54% in adjacent tissues (χ2=29.216, 33.639, 67.483; P<0.05). The positive rates of CK19, Ki67 and CK7 were higher in HCC patients with TNM stage III~IV, poorly differentiated tissue, lymph node metastasis and capsule infiltration (P<0.05). The positive rates of CK7, CK19 and Ki67 in patients with lymph node metastasis and capsule infiltration were higher (P<0.05). The 3-year survival rates of CK19, Ki67 and CK7 positive HCC patients were 34.52%, 58.33% and 58.70% respectively, which were lower than those of 87.18%, 88.24% and 84.21% in negative HCC patients (Log-rank=19.250, 4.767, 3.910; P<0.05).Conclusion The expression levels of CK19, Ki67 and CK7 were highly correlated with TNM stage, tissue differentiation, lymph node metastasis and capsule infiltration, and have impact on the survival of HCC patients.
    The therapeutic effect and adverse events of lenvatinib combined with PD-1 inhibitor in the treatment of advanced liver cancer
    WANG Lu, SUN Xiao-hu, BAI Jing-hui
    2022, 27(8):  891-894. 
    Asbtract ( 459 )   PDF (707KB) ( 238 )  
    References | Related Articles | Metrics
    Objective To investigate the therapeutic effect and adverse events of Lenvatinib combined with PD-1 inhibitor in the treatment of advanced liver cancer.Methods A retrospective analysis was performed for the clinical data of 48 patients hospitalized with advanced liver cancer from January 1, 2019 to January 1, 2021 who were treated with Lenvatinib combined with Pabolizumab as a PD-1 inhibitor. The treatment outcome of intrahepatic lesions was evaluated with Modified Response Evaluation Criteria in Solid Tumors (mRECIST), during follow-up, and RECISTL1.1 was used to evaluate extrahepatic metastatic lesions. Kaplan-Meier method was used to evaluate the patients' survival time.Results Among the 48 patients with treatment experience, 21 achieved partial response, 15 achieved stabilization, and 12 had disease progression. The resulting Objective response rate was 43.75% and the disease control rate was 75.0%. The median time without disease progression was 7.39 (95% confidence interval 5.88-8.92) months. The incidence rate of adverse events was 52.08%. The most common adverse events were rash (31.25%), fatigue (31.25%) and hypertension (27.08%).Conclusion Lenvatinib combined with PD-1 inhibitor has a marked clinical effect in the treatment of advanced primary liver cancer, with a low incidence rate of serious adverse events It is therefore a safe and effective treatment regimen. This treatment is worthy of clinical promotion.
    Comparison of the diagnostic value of multi-slice spiral CT and high field magnetic resonance LAVA enhancement in small hepatocellular carcinoma in the background of hepatitis B cirrhosis
    XIE Hui, WANG Liang-liang, JIANG Kai, YUAN Xiao
    2022, 27(8):  895-897. 
    Asbtract ( 191 )   PDF (754KB) ( 239 )  
    References | Related Articles | Metrics
    Objective To compare the accuracy of multi-slice spiral CT and high field magnetic resonance imaging (MRI) liver acceleration volume acquisition (LAVA) in the diagnosis of small hepatocellular carcinoma (HCC) in the background of hepatitis B cirrhosis.Methods The clinical records of 72 patients with small HCC with hepatitis B cirrhosis background treated in our hospital from July 2019 to December 2021 were analyzed retrospectively. The diagnosis was confirmed by pathological test as the gold standard, and 100 patients with benign liver nodules with hepatitis B cirrhosis background were selected as control. The detection rates of multi-slice spiral CT and MRI in small HCC lesions and benign liver lesions were compared. ROC analysis was used to evaluate the diagnostic value of multi-slice spiral CT and MRI in small HCC.Results A total of 80 lesions were detected in 72 patients with small HCC in the background of hepatitis B cirrhosis. 65 and 74 lesions were detected by multi-slice spiral CT and MRI respectively. The detection rate of lesions by MRI was higher than that by multi-slice spiral CT (χ2=4.440, P=0.035). Among the 100 patients with benign liver lesions, there were 63 cases of hepatic cyst, 27 cases of hepatic hemangioma and 10 cases of hepatic inflammatory mass. 83 cases were detected by multi-slice spiral CT and 91 cases by MRI. There was no significant difference in the detection rate of benign liver lesions between the two groups (χ2=2.829, P=0.093). The positive rate of arterial phase in CT scan was higher than that in plain scan (P<0.05). The positive detection rate of arterial phase in MRI was higher than that in T2WI and T1WI (both P<0.05). MRI was more effective than CT in the diagnosis of small HCC (P<0.05).Conclusion Compared with multi-slice spiral CT scanning, the application of LAVA sequence in high field MRI scanning can more accurately diagnose small HCC.
    Other Liver Diseases
    Circuit lifespan during continuous renal replacement therapy in 319 patients with hepatic insufficiency
    LIU Hai-xia, DUAN Zhong-hui, LAI Mai, XU Man-man, MENG Qing-hua, CHEN Yu
    2022, 27(8):  898-902. 
    Asbtract ( 173 )   PDF (903KB) ( 180 )  
    References | Related Articles | Metrics
    Objective To evaluates the circuit lifespan and complications of CRRT in patients with hepatic insufficiency using different anticoagulation agents.Methods Retrospective analysis of 319 patients with severe liver injury treated with CRRT in the Department of critical medicine of Beijing You'an Hospital in recent 12 years. The effects of systemic heparin, regional citrate anticoagulation (RCA) and non-anticoagulation on circuit lifespan and complications were analyzed. The risk factors affecting circuit lifespan were analyzed.Results The circuit lifespan without anticoagulation was 10 (6,21) hours and was not prolonged by heparin in patients with hepatic insufficiency [13 (9,23), P=0.203]. The circuit lifespan was 21 (11, 56) h anticoagulated with citrate, which was significantly longer than heparin (P=0.000). Bleeding occurred in 30.8% of patients with heparin, while it was 4.2% in RCA. But, the incidence of total calcium / ionized calcium > 2.5 was 25.8% and the incidence of metabolic acidosis and metabolic alkalosis were 16.8 and 12.1% respectively, which were higher than those in the other two groups (P<0.05). Multivariate Cox regression proportional hazards model analysis revealed that liver failure(HR=1.49 ,95%CI:1.16~1.90) and non-citrate anticoagulation(HR=0.51,95%CI:0.43~0.62) were risk factors for circuit life < 48h.Conclusion The circuit lifespan of CRRT in patients with hepatic insufficiency was shortened. Heparin does not provide clinical benefits. RCA can prolong the circuit lifespan but the citrate accumulation must be cautious about. Liver failure and non-RCA were linked to circuit lifespans < 48 hours in patients with liver disease.
    Analysis of liver pathology and clinical features in patients with Epstein-Barr virus infection
    YANG Xian, ZHANG Jing-yi, YANG Wen-xia, TANG Ying-mei
    2022, 27(8):  903-907. 
    Asbtract ( 371 )   PDF (856KB) ( 203 )  
    References | Related Articles | Metrics
    Objective To Study the liver pathology and clinical features of patients with Epstein-Barr virus (EBV) infection, and provide ideas for diagnosis and treatment of EBV hepatitis.Methods Patients' information were collected from July 2015 to July 2020 in the Second Affiliated Hospital of Kunming Medical University. These patients all underwent liver biopsy, in situ hybridization staining of EBV-encoded RNA (EBER) and EBV DNA serology. According to the EBV DNA results, the patients were divided into EBV infection group and non-infected group. There were 15 patients in the EBV infection group and 41 patients in the non-infected group. The reasons for visits, discharge diagnosis, histopathological characteristics and EBER results of patients with EBV infection were analyzed, and the basic information and laboratory indicators of two groups were compared.Results Patients in the infection group came to our hospital with different symptoms or only abnormal liver enzymes. In addition to EBV infection, 9 people had other liver diseases at the time of discharge, and 3 of them had autoimmune liver diseases (all of which were newly diagnosed). Among all the patients undergoing EBER examination, only one patient in the infection group was EBER positive, and the other were negative. The EBER-positive patient didn't have characteristic microscopic findings related to EBV hepatitis including a diffuse lymphocytic sinusoidal infiltrate in a “string of beads” pattern. There were significant differences in age (P=0.012) and globulin (P=0.032) between the EBV infection group and the non-infected group.Conclusion The clinical manifestations of EBV infection are not specific, the possibility of EBV infection should be considered especially when patients with liver injury. Although there are many patients with EBV infection, EBV hepatitis is rare, and the pathological features may not be characteristic. When patients with EBV infection have fever, hepatosplenomegaly and so on, the EBER is an important auxiliary method for diagnosing EBV hepatitis. EBV infection with autoimmune liver disease is not rare, and EBV may play an important role in the occurrence and development of autoimmune liver disease. Further research is still needed to determine whether EBV is just an innocent bystander or a real pathogen.
    Clinical and liver pathological features and mutation of UGT1A1 Gene in a case with Crigler-Najjar Syndrome type Ⅱ
    XU jing, DONG yuan, WANG Shou-ming, HAO Kun-yan, YU Yue-cheng
    2022, 27(8):  908-911. 
    Asbtract ( 679 )   PDF (1043KB) ( 225 )  
    References | Related Articles | Metrics
    Objective Through analyzing the clinical, liver pathology and family uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) gene mutation characteristics of a patient with hereditary hyperbilirubinemia, in order to understand the genetic characteristics and diagnostic methods of Crigler-Najjar Syndrome type Ⅱ.Methods The medical history, liver biochemistry, imaging examination results, liver pathological data of a patient with Crigler-Najjar Syndrome type Ⅱ were collected, we also analyzed the UGT1A1 gene sequencing results of this patient and his parents.Results The increase of bilirubin in patients with Crigler-Najjar Syndrome type Ⅱ was usually greater than 5 times the upper limit of normal value, which was a significant increase in indirect bilirubin (IBIL). ALT and AST of the patient were normal, inflammation and necrosis of hepatocytes were seldom in hepatic pathology from the patient. The patient was a homozygous mutation in UGT1A1 gene Exon 5 c.1456T>G (p.Tyr486Asp), and heterozygotes of the mutation were found in his parents. The treatment of Phenobarbital was effective.Conclusion Missense mutation of Tyr486Asp in Exon 5 of UGT1A1 gene is the pathogenic factor of this patient with Crigler-Najjar Syndrome type Ⅱ and his family, which is autosomal recessive inheritance, with significantly increased IBIL. There is no inflammatory injury in the liver, and phenobarbital induction is effective.
    Incidence of dyslipidemia and distribution characteristics of blood lipids in patients with obstructive jaundice
    WANG Chuan, CHEN Pei-xian, SU Shu-ying, CHEN Huan-wei
    2022, 27(8):  912-914. 
    Asbtract ( 153 )   PDF (714KB) ( 240 )  
    References | Related Articles | Metrics
    Objective To analyze the occurrence of dyslipidemia in patients with obstructive jaundice (OJ), and to understand the difference and clinical significance between the distribution characteristics of blood lipids in OJ patients with dyslipidemia and patients with OJ alone.Methods Reviewing the medical records of OJ patients admitted to hospital and followed up in outpatient department from January 2017 to December 2020, 112 cases (65 males and 47 females) were included, with the age of 62 (41, 72) years old. According to the blood lipid level, they were divided into single OJ group and OJ dyslipidemia group. The diagnosis of OJ met the requirements. The diagnosis of dyslipidemia accords with at least one of following items: total cholesterin (TC) ≥ 5.18 mmol/L, triglycerides (TG) ≥ 3.5 mmol/L, high density lipoprotein (HDL) ≤ 1.04 mmol/L or low density lipoprotein (LDL) ≥ 3.37 mmol/L. The laboratory examination results of single OJ group and OJ dyslipidemia group were compared, and the correlation between lipid indexes and liver function indexes of OJ dyslipidemia patients was analyzed by Spearman test.Results Among the 112 patients with OJ, the single OJ group and the OJ dyslipidemia group were 39 cases and 73 cases respectively, and the incidence of dyslipidemia in OJ patients was 65.2%. The causes of OJ include 97 cases of biliary calculi (86.6%), 6 cases of pancreatic cancer (5.3%), 5 cases of biliary stricture caused by biliary surgery (4.5%), 2 cases of congenital biliary stricture (1.8%) and 2 cases of autoimmune liver disease (1.8%). Dyslipidemia accounted for 65.2% of OJ patients, of which 34 cases (46.6%) had elevated TG, 47 cases (64.4%) had elevated TC, 42 cases (57.5%) had elevated LDL and 21 cases (28.8%) had decreased HDL. Comparing the laboratory examination results of single OJ group and OJ dyslipidemia group, the albumin (Alb), alaninetransaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyl transferase (GGT) and total bilirubin (Tbil) in single OJ group were 40.2 (36.7, 44.7) g/L, 60 (33, 108) U/L, 56 (34, 103) U/L, 212 (120, 352) U/L, 214 (78, 420) U/L and 37.2 (17.8, 78.5) μmol/L, which was significantly higher than those of OJ dyslipidemia group [33.2 (29.6, 36.9) g/L, 92 (57, 202) U/L, 104 (61, 180) U/L, 394 (265, 678) U/L, 355 (167, 730) U/L and 218.0 (141.7, 301.6) μmol/L, Z=-2.084, 3.204, 3.412, 2.824, 2.908 and 7.538, P<0.05]. TG, TC, LDL and HDL in single OJ group were 1.2 (0.9, 1.6) mmol/L, 4.2 (3.6, 5.2) mmol/L, 1.3 (0.7, 2.4) mmol/L and 1.0 (0.8, 1.4) mmol/L, which were significantly different from those in OJ dyslipidemia group [2.2 (1.5, 2.9) mmol/L, 5.0 (3.9, 7.3) mmol/L, 2.4 (1.8, 3.1) mmol/L and 0.2 (0.1, 0.3) mmol/L, Z=2.229, 2.054, 2.224 and -5.418, P<0.05]. Spearman correlation analysis showed that Alb, ALT, ALP and GGT levels in OJ patients with dyslipidemia were well correlated with lipid indexes (r>0.3).Conclusion Hypercholesterolemia is the most common in OJ patients with dyslipidemia, and liver function indexes such as Alb, ALT, ALP and GGT have a good correlation with lipid indexes.    
    Clinical value of combined detection of serum sFlt-1 and PlGF levels on severity and prognosis of acute fatty liver disease in pregnancy
    ZHANG Wen-ting, XU Xiao-ying, LU Rong
    2022, 27(8):  915-919. 
    Asbtract ( 173 )   PDF (698KB) ( 230 )  
    References | Related Articles | Metrics
    Objective To explore the value of combined detection of soluble FMS like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) in evaluating the severity and prognosis of acute fatty liver during pregnancy (AFLP).Methods 35 AFLP patients admitted from January 2018 to July 2021 were included in the observation group. According to the level of prothrombin activity (PTA), they were divided into mild group and severe group, and were divided into easy to cure group and difficult to cure group according to the cure time. Thirty-five healthy pregnant women were included in the control group. The serum levels of sFlt-1, PlGF, postprandial blood glucose (PBG), albumin (Alb), total bilirubin (TBil), prothrombin time (PT) and creatinine (Cr) in the observation group and the control group were compared. The levels of serum sFlt-1 and PlGF in subgroups with different severity of disease and different cure time were compared. The correlation between serum sFlt-1 and PlGF levels and PBG, Alb, TBil, PT and Cr levels was compared, and the diagnostic efficacy of sFlt-1 and PlGF levels alone and combined detection was analyzed by regression analysis.Results The serum sFlt-1 level in the observation group (3829.57±506.41 pg/mL) was higher than that in the control group (516.48±87.25 pg/mL), and the serum PlGF level (152.64±35.17 pg/mL) was lower than that in the control group (375.62±74.38 pg/mL). The difference was statistically significant (t=187.258, 16.492, P<0.05). The levels of TBil, Cr and PT in observation group were significantly higher than those in control group, while the levels of PBG and Alb were lower than those in control groups (P<0.05). In the observation group, the serum sFlt-1 levels of severe and difficult to cure groups (5024.86±638.57 pg/mL, 4659.27±471.83 pg/mL) were higher than those of mild and easy to cure groups (2908.59±304.80 pg/mL, 3260.85±369.42 pg/mL), respectively, and the difference was statistically significant (t=25.385, 19.473, P<0.05). PlGF levels (98.38±27.35 pg/mL, 107.34±29.68 pg/mL) were lower than those of mild and difficult to cure groups (187.45±48.61 pg/mL, 172.56±45.19 pg/mL), and the difference was statistically significant (t=19.276, 14.725, P<0.05). Pearson analysis showed that the serum sFlt-1 level of AFLP patients was negatively correlated with PBG and Alb levels, but positively correlated with TBil, Cr and PT levels (P<0.05). Serum PlGF levels were positively correlated with PBG and Alb levels, but negatively correlated with TBil, Cr and PT levels (P<0.05). Receiver operating characteristic (ROC) curve showed that the area under curve (AUC) of sFlt-1, PlGF and combined detection for AFLP diagnosis were 0.925, 0.903 and 0.976, respectively, indicating that combined detection was significantly more efficient than any single detection (P<0.05).Conclusion Serum sFlt-1 and PlGF levels have higher clinical value in evaluating the severity and prognosis of AFLP patients, and the combined detection is more effective.
    The effect of microRNA-219 on lipid metabolism, cell viability and apoptosis of hepatocytes under lipotoxic environment
    XU Zi-xin, LIAO Hong-yu, LI Hui-yi, XU Ming-yi
    2022, 27(8):  920-924. 
    Asbtract ( 118 )   PDF (1130KB) ( 194 )  
    References | Related Articles | Metrics
    Objective To explore the effect of microRNA-219 (miR-219) on lipid metabolism, cell viability and apoptosis of lipotoxic hepatocytes.Methods Mice were fed with low-fat diet (LFD) and high-fat diet (HFD) to construct control group and non-alcoholic fatty liver diseases (NAFLD) model. Hematoxylin-eosin (H&E) staining and oil red staining were used to observe the liver histology. Primary hepatocytes (PHCs) were isolated from wild-type mice and then incubated with 200uM palmitic acid (PA) for 24h to mimic a high-fat environment. Fatty degeneration of hepatocytes was judged by oil red staining, aspartate transaminase (AST) and alanine aminotransferase (ALT) levels. Quantitative polymerase chain reaction (q-PCR) was used to detect the expression of miR-219 in liver tissue and PHCs, and the mRNA expression of lipid metabolism factors [stearoyl-CoA desaturase 1 (SCD1) and fatty acid synthase (FASN)], proliferation-related factors [proliferating cell nuclear antigen (PCNA) and CyclinD1] and apoptosis-related factors [B-cell lymphoma-2 (BCL-2) and Caspase3] after overexpression of miR-219 through miR-219 mimic (mi-miR-219) or the negative control in PA-treated PHCs. Oil red staining was performed to observe cell lipid deposition. EDU was used to observe cell proliferation.Results The NAFLD mice model was successfully established. Compared with the relatively control group, miR-219 expression was significantly decreased in both the liver tissues of HFD group and PA-treated PHCs [HFD group: (0.455±0.028), LFD group: (1.000±0.125), P<0.05; PA-treated group: (0.676±0.064), Control: (1.000±0.190), P<0.05]. After overexpressing miR-219, SCD1 and FASN mRNA expression were both significantly decreased in PA-treated PHCs [SCD1: mi-miR-219+PA: (0.539±0.048), negative control group (miR-NC)+PA: (1.000±0.033), P<0.001; FASN: mi-miR-219+PA: (0.722±0.036), miR-NC+PA: (1.000±0.051), P<0.05]. Oil red staining indicated that the lipid deposition was also significantly alleviated in PA-treated PHC in mi-miR-219 group. Compared with the miR-NC group, the mRNA expression of proliferation-related factors was both obviously increased [PCNA: mi-miR-219+PA: (1.652±0.185), miR-NC+PA: (1.000±0.203), P<0.05; CyclinD1: mi-miR-219+PA: (1.791±0.154), miR-NC+PA: (1.000±0.135), P<0.05]. And the more obvious red fluorescent was showed in mi-miR-219 PHCs group according to EDU assay. Besides, the mRNA expression of pro-apoptotic factor Caspase-3 was decreased [mi-miR-219+PA: (0.574±0.054), miR-NC+PA: (1.000±0.35), P<0.05], but the mRNA expression of anti-apoptotic factor BCL-2 was increased [mi-miR-291: (1.535±0.109), miR-NC: (1.000±0.208), P<0.05].Conclusion Under high-fat environment, miR-219 could significantly alleviate hepatocytes lipid deposition, promote hepatocytes viability and inhibit cell apoptosis to delay the progress of NAFLD.